As of January 22, 2025, Sutro Biopharma (STRO) has a market cap of $0.16 billion USD. According to our data, Sutro Biopharma is ranked No.7310 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.16 B |
6.25%
|
Dec 31, 2024 | $0.15 B |
-57.11%
|
Dec 29, 2023 | $0.35 B |
-46.91%
|
Dec 30, 2022 | $0.67 B |
-45.70%
|
Dec 31, 2021 | $1.23 B |
-31.46%
|
Dec 31, 2020 | $1.79 B |
97.36%
|
Dec 31, 2019 | $0.91 B |
21.95%
|
Dec 31, 2018 | $0.74 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.20 B |
-0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Market Cap | = | STRO Stock Price | * | STRO Shares Outstanding |
= | $1.96 | * | 82.46 M | |
= | $0.16 B |